Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bremelanotide in Female Sexual Arousal Disorder
NCT00425256Phase 2Completed
- Sponsor
- Palatin Technologies, Inc.
- Start
- Feb 2006
- Primary completion
- May 2007
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bremelanotide in Sexual Arousal Disorder, sponsored by Palatin Technologies, Inc.. Started Feb 2006; status: completed.
02
Drugs
bremelanotide
03
Conditions
Sexual Arousal Disorder
Beyond the preview
Go deeper on NCT00425256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00425256.